<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>We have evaluated the frequency of KRAS gene mutations during the critical transition from villous <z:mpath ids='MPATH_270'>adenoma</z:mpath> to colorectal <z:mp ids='MP_0002038'>carcinoma</z:mp> to assess whether the <z:mpath ids='MPATH_270'>adenomas</z:mpath> contain a KRAS mutation more frequently than <z:mp ids='MP_0002038'>carcinomas</z:mp> </plain></SENT>
<SENT sid="1" pm="."><plain>We analyzed <z:hpo ids='HP_0003745'>sporadic</z:hpo> villous and tubulovillous <z:mpath ids='MPATH_270'>adenomas</z:mpath>, in situ <z:mp ids='MP_0002038'>carcinomas</z:mp>, and primary colorectal <z:mp ids='MP_0002038'>carcinomas</z:mp> from multiple patients </plain></SENT>
<SENT sid="2" pm="."><plain>The <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancers</z:e> were further evaluated for mucinous status and microsatellite instability </plain></SENT>
<SENT sid="3" pm="."><plain>Standard PCR molecular techniques were used for KRAS and microsatellite analyses </plain></SENT>
<SENT sid="4" pm="."><plain>A KRAS mutation was found in 61.9% of 134 <z:mpath ids='MPATH_270'>adenomas</z:mpath>, 67.8% of 84 in situ <z:mp ids='MP_0002038'>carcinomas</z:mp>, and just 31.6% of 171 <z:mp ids='MP_0002038'>carcinomas</z:mp> </plain></SENT>
<SENT sid="5" pm="."><plain>Our study clearly demonstrates that tubulovillous and villous <z:mpath ids='MPATH_270'>adenomas</z:mpath>, as well as both the benign and malignant parts of in situ <z:mp ids='MP_0002038'>carcinomas</z:mp>, are statistically more likely to contain a somatic KRAS gene mutation than colorectal <z:mp ids='MP_0002038'>carcinomas</z:mp> </plain></SENT>
<SENT sid="6" pm="."><plain>This difference is confined to the non-mucinous and the microsatellite stable <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> </plain></SENT>
<SENT sid="7" pm="."><plain>Our data support the possibility that non-mucinous and microsatellite stable <z:mp ids='MP_0002038'>carcinomas</z:mp> with <z:mp ids='MP_0002169'>wild-type</z:mp> KRAS gene may have had a mutation in the KRAS gene during their earlier stages, with the mutation lost during further growth </plain></SENT>
</text></document>